Skip to content

New patient pricing is live · From $149/mo, flat at every dose · Free to start

Peptides

TB-500 vs BPC-157: How the Two Compare

TB-500 and BPC-157 are two repair-signaling peptides often mentioned together. Here is how their mechanisms and evidence differ, in plain English.

By Toned Team · Reviewed by the Toned editorial team

Published April 29, 2026 · Last reviewed July 7, 2026 · 2 min read

TB-500 and BPC-157 are two peptides studied for tissue-repair signaling, and they get mentioned in the same breath so often that people assume they are variations on one theme. They are not. They come from different biology and act through different mechanisms — and both share the same honest caveat: the human evidence is thin.

What is TB-500?

TB-500 is a synthetic version of a fragment of thymosin beta-4, a naturally occurring protein involved in cell migration, actin regulation, and blood-vessel signaling — the peptide glossary defines the terms used here. Research — largely preclinical — has examined its role in wound repair and tissue regeneration. The interest comes from thymosin beta-4's genuine biological role; the limitation is how little of that has been tested rigorously in humans.

What is BPC-157?

BPC-157 is a stable synthetic peptide derived from a protein in gastric juice, studied mostly in animal models for tendon, muscle, and gastrointestinal repair signaling. Our full BPC-157 research overview goes deeper, but the short version is the same shape as TB-500: interesting preclinical work, scarce human trials.

How do they differ?

  • Origin. TB-500 traces to thymosin beta-4; BPC-157 to a gastric protein fragment.
  • Mechanism emphasis. TB-500 research centers on cell migration and blood-vessel signaling; BPC-157 on tendon, muscle, and gut repair pathways.
  • Evidence. Both are overwhelmingly preclinical; neither is FDA-approved or backed by strong human trials.

Which one is "better"?

That framing does not really fit the evidence. Neither has the human data to crown a winner, and the right question is not "which peptide" but "is any of this appropriate for me" — a question for a licensed provider. Toned does not currently offer either compound; both are covered here for education only.

The through-line: these are studied for repair, not proven to deliver it in humans. Keep the language accurate, and keep a clinician in the loop. What Toned does prescribe today is compounded GLP-1 medication — see how it works.

References

  1. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005. PubMed
  2. Sikiric P et al. Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract healing. Curr Pharm Des. 2018. PubMed
  3. Xing Y et al. Progress on the function and application of thymosin β4. Front Endocrinol (Lausanne). 2021. PubMed
  4. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012. PubMed
  5. Kleinman HK, Sosne G. Thymosin β4 promotes dermal healing. Vitam Horm. 2016. PubMed

This article is for general education and is not medical advice. Talk to a licensed provider about your individual situation.

FAQ

Questions this article answers.

More questions answered in the full FAQ.

Your future self says hi.

Five minutes online today. A licensed provider handles the rest — and you never sit in a waiting room.

Get started — it's free

Takes ~5 min · 100% online · No insurance needed